Skip to main content

Endovascular treatment of chronic superficial femoral artery (SFA) occlusion for limb salvage

Case takeaways

  • Limb salvage by endoluminal bypass in Rutherford 6 limb
  • While initial PTA demonstrated a good result, diabetic patients have diffuse disease and the arteriogram understates the plaque burden in these patients
  • Cover healthy-to-healthy to the extent possible

We opt for greater stent coverage beyond the segment of disease.
We also employ oblique views of the take-off of the SFA so we can treat the diseased artery at the take-off of the SFA without compromising flow in the profunda femoris artery.

 — James Persky, MD, Cleveland, Ohio

TERUMO and GLIDEWIRE® are trademarks of Terumo Medical Corporation.
SPECTRANETICS® and QUICK CROSS are trademarks of Spectranetics Corporation.

The outcomes and observations reported are based on individual case experience and the patients treated. The steps described here may not be complete, and are not intended to be a replacement for the Instructions for Use or the education, training and professional judgment of Healthcare Providers. Healthcare Providers remain solely responsible for making decisions about patient care and the use of medical technologies. 

Refer to Instructions for Use at eifu.goremedical.com for complete description of all indications, warnings, precautions and contraindications for the markets where this product is available.  

Visit our clinical uses page